Functional tissue-engineered blood vessels from bone marrow progenitor cells
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Stem cells have significant potential for development of cell-based therapeutics for cardiovascular tissue regeneration. METHODS: We developed a novel method for isolating smooth muscle cells (SMC) from ovine bone marrow using a tissue-specific promoter and fluorescence-activated cell sorting. RESULTS: As compared to vascular SMC, bone marrow-derived smooth muscle progenitor cells (BM-SMPC) exhibited similar morphology, showed higher proliferation potential and expressed several SMC markers including alpha-actin, calponin, myosin heavy chain, smoothelin, caldesmon and SM22. When embedded in fibrin hydrogels, BM-SMPC contracted the matrix and displayed receptor- and non-receptor-mediated contractility, indicating that BM-SMPC can generate force in response to vasoreactive agonists. We also prepared tissue-engineered blood vessels from BM-SMPC and BM-derived endothelial cells and implanted them into the jugular veins of lambs. As early as five weeks post-implantation, grafted tissues displayed a confluent endothelial layer overlaying the medial layer in which BM-SMPC were aligned circumferentially and synthesized significant amounts of collagen. In contrast to previous results with vascular SMC, BM-SMPC synthesized high amounts of elastin that was organized in a fibrillar network very similar to that of native vessels. CONCLUSIONS: Our results suggest that BM-SMPC may be useful in studying SMC differentiation and have high potential for development of cell therapies for the treatment of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smad3 Mediates Transforming Growth Factor-β–Induced α-Smooth Muscle Actin Expression
Hu, B., Wu, Z., & Phan, S. H. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0063oc · Cited by 325
Cited by
Fibrin: A versatile scaffold for tissue engineering applications
Ahmed, T. A. E., Dare, E. V., & Hincke, M. (2008) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2007.0435 · Cited by 994
“48,49 In addition, fibrin hydrogels have applications for promoting angiogenesis 50–52 and enhancing neurite extension.”
The Tissue-Engineered Vascular Graft—Past, Present, and Future
Pashneh-Tala, S., MacNeil, S., & Claeyssens, F. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0100 · Cited by 798
Konig, G., McAllister, T. N., Dusserre, N., Garrido, S. A., Iyican, C., Marini, A., Fiorillo, A., Avila, H., Wystrychowski, W., Zagalski, K., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.11.011 · Cited by 582
Beamish, J. A., He, P., Kottke-Marchant, K., & Marchant, R. E. (2010) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2009.0630 · Cited by 383
Small‐diameter human vessel wall engineered from bone marrow‐derived mesenchymal stem cells (hMSCs)
Gong, Z., & Niklason, L. E. (2008) · The FASEB Journal · doi:10.1096/fj.07-087924 · Cited by 325
Metadata
- Authors
- LIU, J., SWARTZ, D., PENG, H., GUGINO, S., RUSSELL, J., & ANDREADIS, S.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-08-01
- Volume
- 75
- Issue
- 3
- Pages
- 618-628
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2147547629
- Cited by
- 118
- References
- 1
- FWCI
- 11.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Functional tissue-engineered blood vessels from bone marrow progenitor cells. https://app.cochat.ai/papers/10.1016/j.cardiores.2007.04.018
- The paper
- LIU, J., SWARTZ, D., PENG, H., GUGINO, S., RUSSELL, J., & ANDREADIS, S. (2007). Functional tissue-engineered blood vessels from bone marrow progenitor cells. Cardiovascular Research. https://doi.org/10.1016/j.cardiores.2007.04.018
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.